CRL - Charles River Laboratories International, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,681,4321,363,3021,297,662
Cost of Revenue1,034,766832,210825,002
Gross Profit646,666531,092472,660
Operating Expenses
Research Development---
Selling General and Administrative367,548300,414269,033
Non Recurring---
Total Operating Expenses---
Operating Income or Loss237,419206,449177,670
Income from Continuing Operations
Total Other Income/Expenses Net13,2114,05111,875
Earnings Before Interest and Taxes250,630210,500189,545
Interest Expense27,70915,07211,950
Income Before Tax222,921195,428177,595
Income Tax Expense66,83543,39147,671
Minority Interest2,3574,4893,724
Net Income From Continuing Ops156,086152,037129,924
Non-recurring Events
Discontinued Operations280-950-1,726
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income156,366151,087128,198
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares154,765149,313126,698